COVID digest: BioNTech-Pfizer start trial of omicron-specific vaccine

Pharmaceutical firms BioNTech and Pfizer have started a clinical trial of an omicron-specific COVID-19 vaccine. Meanwhile, an expert panel in Israel has recommended a 4th jab for adults. Follow DW for more.